This mechanism by which autonomic innervation mediates vascular endothelial growth factor (VEGF)-driven angiogenesis may also explain why pharmacological inhibition of the VEGF pathway with targeted agents, such as Bevacizumab and Sorafenib, have shown variable utility in the prevention of cancer progression. Here, VEGFA is linked to cancer.